Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments

Journal of Neurology 2026

View at publisher
Authors: Giacomo Greco, Giovanni Porta, Francesco Masi, Chiara Redemagni, Lara Ahmad, Eduardo Caverzasi, Roberto Bergamaschi, Michele Terzaghi, Matteo Gastaldi, Eleonora Rigoni, Anna Pichiecchio, Elena Colombo
+1 more Eleonora Tavazzi
DOI: 10.1007/s00415-025-13611-1
Cited by: 0
References: 37

Fields of Study & Subjects

Multiple Sclerosis Research Studies Glaucoma and retinal disorders Drug-Induced Ocular Toxicity

Publication details

Journal / source
Journal of Neurology
Volume
273
Issue
1
Pages
77–77
Publication date
1 January 2026
Language
EN